Is breast augmentation with autologous fat transplantation often unsuccessful?
Autologous fat breast augmentation involves transplanting excess fat cells from other areas of the body to the chest through injection, allowing the fat cells to regrow and integrate with the chest tissue, thereby increasing breast volume and improving breast shape. The general reference price for autologous fat breast augmentation is 10,000-30,000 yuan per session, with noticeable improvement typically visible after 2-3 months. Generally speaking, cases of failure with autologous fat breast augmentation are rare, and doctors usually ensure the safety of the procedure. It is recommended to visit a正规 hospital and undergo the surgery under the guidance of a qualified physician. Detailed analysis is as follows:
During autologous fat breast augmentation, since the transplanted fat cells come from the patient's own body, there is no risk of immune rejection, fundamentally ensuring the safety of the surgery. If performed correctly, satisfactory breast augmentation results are usually achievable after the procedure. However, there are still certain risks of failure associated with autologous fat breast augmentation. If surgical techniques are improperly executed during the procedure—for example, problems occurring during fat extraction, processing, or injection—complications such as uneven fat absorption or infection may arise, affecting the surgical outcome. Additionally, individual physical conditions can also influence the success rate of the surgery. If the patient's fat cell quality is poor or the baseline condition of the chest is suboptimal, this may affect fat cell survival rates and overall surgical results.
To reduce the risk of failure in autologous fat breast augmentation, it is essential to strictly follow the surgeon's instructions during the procedure. Postoperatively, it is equally important to adhere to medical advice for proper care, including wound cleanliness, adequate rest, and other measures to promote recovery.